CLEARVIEW WEALTH LIMITED (CVW)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CVW - CLEARVIEW WEALTH LIMITED

FNArena Sector : Insurance

Year End: June

GICS Industry Group : Diversified Financials

Debt/EBITDA: 4.83

Index: ALL-ORDS

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$0.46 02 Apr 2025	-0.010 OPEN $0.47	-2.13% HIGH $0.48	541,934 LOW $0.45

TARGET

$0.65

41.3% upside

Franking for last dividend paid out: 100%

OTHER COMPANIES IN THE SAME SECTOR
AUB . FCL . GDG . HLI . IAG . MPL . NHF . NOL . QBE . SDF . SUN . TWR .

FNARENA'S MARKET CONSENSUS FORECASTS

Title	FY23 Actual	FY24 Actual	FY25 Forecast	FY26 Forecast
EPS (cps)	xxx	- 1.6	4.9	xxx
DPS (cps)	xxx	3.2	0.0	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	6.7%	N/A	xxx
PE Ratio	xxx	N/A	9.7	xxx
Dividend Yield	xxx	N/A	0.0%	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

Dividend yield today if purchased 3 years ago: 4.21%

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/09 - ex-div 1.7c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2025 FactSet UK Limited. All rights reserved

Title	2019	2020	2021	2022	2023	2024
EPS Basic	xxx	xxx	xxx	xxx	xxx	-1.6
DPS All	xxx	xxx	xxx	xxx	xxx	3.2
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	416.6 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	54.8
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	3.9 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	1.68 %

EPS Basic

Negative
Growth
Slowing

DPS All

Negative
Growth
Slowing

Sales/Revenue

Negative
Growth
Slowing

Book Value Per Share

Negative
Growth
Slowing

Net Operating Cash Flow

Negative
Growth
Slowing

Net Profit Margin

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	1.67 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	1.34 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	0.26 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	1.67 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	3.03 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	-25.8 M

Return on Capital Employed

Negative
Growth
Slowing

Return on Invested Capital

Negative
Growth
Slowing

Return on Assets

Negative
Growth
Slowing

Return on Equity

Negative
Growth
Slowing

Return on Total Capital

Negative
Growth
Slowing

Free Cash Flow ex dividends

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	0 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	111 M
Total Debt	xxx	xxx	xxx	xxx	xxx	111 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	12 M
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	101 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	1.10

Short-Term Debt

Negative
Growth
Slowing

Long Term Debt

Negative
Growth
Slowing

Total Debt

Negative
Growth
Slowing

Goodwill - Gross

Negative
Growth
Slowing

Cash & Equivalents - Generic

Negative
Growth
Slowing

Price To Book Value

Negative
Growth
Slowing

Title	2019	2020	2021	2022	2023	2024
Capex	xxx	xxx	xxx	xxx	xxx	11.9 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	2.85 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	391 M
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	10 M
Research & Development	xxx	xxx	xxx	xxx	xxx	-
Investments - Total	xxx	xxx	xxx	xxx	xxx	424 M

Capex

Negative
Growth
Slowing

Capex % of Sales

Negative
Growth
Slowing

Cost of Goods Sold

Negative
Growth
Slowing

Selling, General & Admin. Exp & Other

Negative
Growth
Slowing

Research & Development

Investments - Total

Negative
Growth
Slowing

Negative

Growth

Slowing

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Morgans	28/02/2025	1	Add	$0.65	41.30%	Morgans says ClearView Wealth's 1H25 result showed a strong recovery after a challenging 1Q25, with claims normalising and all key FY26 targets reaffirmed, the analyst explains. The broker points to an increase in gross premium targets and stronger-than-expected top-line growth. Claims volatility in 1Q25 now appears temporary, reducing concerns over long-term profitability. The balance sheet remains solid, supporting growth initiatives and potential capital returns. Management maintains a positive outlook for FY26, expecting operational efficiencies to drive further improvement. Morgans raises FY25/26 EPS forecasts by 2-16% and increases the target price to 65c from 59c. Add rating maintained. FORECAST Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 4.90 cents. Morgans forecasts a full year FY26 dividend of 4.20 cents and EPS of 7.10 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Morgans

28/02/2025

Add

$0.65

41.30%

Morgans says ClearView Wealth's 1H25 result showed a strong recovery after a challenging 1Q25, with claims normalising and all key FY26 targets reaffirmed, the analyst explains.

The broker points to an increase in gross premium targets and stronger-than-expected top-line growth. Claims volatility in 1Q25 now appears temporary, reducing concerns over long-term profitability.

The balance sheet remains solid, supporting growth initiatives and potential capital returns. Management maintains a positive outlook for FY26, expecting operational efficiencies to drive further improvement.

Morgans raises FY25/26 EPS forecasts by 2-16% and increases the target price to 65c from 59c.

Add rating maintained.

FORECAST
Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 4.90 cents.
Morgans forecasts a full year FY26 dividend of 4.20 cents and EPS of 7.10 cents.

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
No data available in table

Access Extra Coverage Research History >

CVW STOCK CHART

FNArena News on CVW

1	FNArena Corporate Results Monitor – 28-02-2025 Feb 28 2025 - Australia

2	Weekly Ratings, Targets, Forecast Changes – 24-01-25 Jan 28 2025 - Weekly Reports

3	Australian Broker Call Extra Edition – Jan 23, 2025 Jan 23 2025 - Daily Market Reports

4	Rudi’s View: Best Buys & Convictions For 2025 Jan 16 2025 - Rudi's View

5	Rudi’s View: Final Best Buys & Conviction Ideas Dec 23 2024 - Rudi's View

Latest Insurance News

1	Insurers To Pamper Shareholders With Buybacks Jan 24 2025 - Australia

2	IAG Shares Breaking Out Jan 21 2025 - Technicals

3	ESG Focus: The Little Big Things – 21-11-2024 Nov 21 2024 - ESG Focus

4	New-Look Suncorp Ready To Rumble Nov 14 2024 - Australia

5	Steadfast’s Long March Jul 02 2024 - Australia

6	AUB Group Shares Poised For Break-Out Jun 13 2024 - Technicals

7	SMSFundamentals: Older People Are Life Insurers’ Future Challenge Oct 26 2023 - SMSFundamentals

8	Australian Insurers And The Weather Oct 19 2023 - Feature Stories

9	Steadfast Group’s US Entry Full Of Promise Oct 11 2023 - Australia

10	Pros And Cons Of Insurance Companies Aug 02 2023 - Australia

Dividend Yield Today On Last Actual Payout :	6.74
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

CLEARVIEW WEALTH LIMITED (CVW)
Share Price Analysis and Chart